| pubmed-article:7727966 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7727966 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7727966 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:7727966 | lifeskim:mentions | umls-concept:C0005767 | lld:lifeskim |
| pubmed-article:7727966 | lifeskim:mentions | umls-concept:C0023516 | lld:lifeskim |
| pubmed-article:7727966 | lifeskim:mentions | umls-concept:C0019721 | lld:lifeskim |
| pubmed-article:7727966 | lifeskim:mentions | umls-concept:C0003261 | lld:lifeskim |
| pubmed-article:7727966 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
| pubmed-article:7727966 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
| pubmed-article:7727966 | lifeskim:mentions | umls-concept:C0333668 | lld:lifeskim |
| pubmed-article:7727966 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:7727966 | pubmed:dateCreated | 1995-6-1 | lld:pubmed |
| pubmed-article:7727966 | pubmed:abstractText | To determine the effect of transfusion therapy with leukocyte-depleted platelet concentrates in comparison to transfusion support with standard platelet concentrates on the frequency of HLA alloimmunization in hematologic-oncologic patients. | lld:pubmed |
| pubmed-article:7727966 | pubmed:language | ger | lld:pubmed |
| pubmed-article:7727966 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7727966 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7727966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7727966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7727966 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7727966 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:7727966 | pubmed:issn | 1019-8466 | lld:pubmed |
| pubmed-article:7727966 | pubmed:author | pubmed-author:SachsVV | lld:pubmed |
| pubmed-article:7727966 | pubmed:author | pubmed-author:ThomsenHH | lld:pubmed |
| pubmed-article:7727966 | pubmed:author | pubmed-author:JinJJ | lld:pubmed |
| pubmed-article:7727966 | pubmed:author | pubmed-author:AdamzikI DID | lld:pubmed |
| pubmed-article:7727966 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7727966 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:7727966 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7727966 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7727966 | pubmed:pagination | 9-13 | lld:pubmed |
| pubmed-article:7727966 | pubmed:dateRevised | 2010-3-12 | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:meshHeading | pubmed-meshheading:7727966-... | lld:pubmed |
| pubmed-article:7727966 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7727966 | pubmed:articleTitle | [Prevention of HLA antibody formation in patients with hemato-oncologic diseases by using leukocyte depleted blood preparations]. | lld:pubmed |
| pubmed-article:7727966 | pubmed:affiliation | Institut für Transfusionsmedizin der Christian-Albrechts-Universität zu Kiel. | lld:pubmed |
| pubmed-article:7727966 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7727966 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7727966 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:7727966 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
